Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of dry eye syndrome
3.2.1.2 Growing awareness and self-care practices
3.2.1.3 Increased screen time and digital device usage
3.2.1.4 Technological advancements in product formulations
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects and allergic reactions
3.2.2.2 Availability of alternative treatments
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Preservative
5.3 Preservative-free
Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Branded
6.3 Generics
Chapter 7 Market Estimates and Forecast, By Viscosity, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Low viscosity
7.3 High viscosity
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Online pharmacies
8.3 Retail pharmacies
8.4 Other distribution channels
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AbbVie, Inc.
10.2 Alcon
10.3 Allergan plc
10.4 Altaire Pharmaceutical Inc.
10.5 Bausch Health Companies Inc.
10.6 IDEX CORPORATION
10.7 Johnson & Johnson
10.8 Medicom Healthcare Pvt Ltd.
10.9 Novartis AG
10.10 OASIS
10.11 Prestige Consumer Healthcare Inc.
10.12 Rohto Pharmaceutical Co., Ltd.
10.13 Similasan Corporation
10.14 Sentiss Pharma Private Limited
